The Brazilian Journal of Infectious Diseases

ISSN: 1413-8670

The Brazilian Journal of Infectious Diseases is the official publication of the Brazilian Society of Infectious Diseases (SBI). It aims to publish relevant articles in the broadest sense on all aspects of microbiology, infectious diseases and immune response to infectious agents.
The BJID is a bimonthly publication and one of the most influential journals in its field in Brazil and Latin America with a high impact factor. Since its inception it has garnered a growing share of the publishing market.

Indexed in:

CABI Publishing; Chemical Abstracts (CAS); China Education Publications Import and Export Corporation (CEPIEC); EBSCO Database (Premium Research); Elsevier Science - Bibliographic Databases Division; Embase/Excerpta Medica; Gale Cengage Learning; Index Copernicus International; ISI (Web of Science) - Science Citation Index Expanded (SCISEARCH); Journal Citation Reports (Science Edition); Kessler-Hancok Information Service; Latin America and Caribean Literature of Health Science (LILACS); LATINDEX; Medline/ Index Medicus/Pubmed; Qualis International (CAPES): B3 (International Quality); Redalyc (Network of Scientific Journals of Latin America, Caribbean, Spain and Portugal) SCIELO; SCIRUS (Elsevier); SCOPUS Index; Sociedad Iberoamericana de Información Cientifica (SIIC); Subis Database (SUBIS Bulletin); Swets Blackwell; Teldan Database Production; The US Library of Congress Office; Ulrich¿s Periodicals Directory.

Statistics

Follow this link to access the full text of the article

AO 17

TROCA PARA UM REGIME COM 2 MEDICAMENTOS DOLUTEGRAVIR / LAMIVUDINA (DTG / 3TC) EM DOSE FIXA COMBINADA É NÃO INFERIOR A CONTINUAR COM UM REGIME DE 3 MEDICAMENTOS POR 48 SEMANAS EM UM ENSAIO CLÍNICO RANDOMIZADO (SALSA)

Josep M. Llibrea, Carlos Britesb, Chien-yu Chengc, Olayemi Osiyemid, Carlos Galerae, Laurent Hocquelouxf, Franco Maggiolog, Olaf Degenh, Libby Blairi, Brian Wynnei, James Oyeej, Mark Underwoodi, Lloyd Curtisj, Gilda Bontempoi, Jean van Wykk, Jucival Fernandesl

a Hospital Universitari Germans Trias i Pujol, Barcelona, Espanha

b Universidade Federal da Bahia (UFBA), Salvador, BA, Brasil

c Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan

d Triple O Research Institute PA, West Palm Beach, Estados Unidos

e Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Espanha

f Centre Hospitalier Régional d'Orléans, Orléans, França

g ASST Papa Giovanni XXIII, Bergamo, Itália

h Universitätsklinikum Hamburg-Eppendorf, Hamburgo, Alemanha

i ViiV Healthcare, Research Triangle Park, Estados Unidos

j GlaxoSmithKline, Brentford, Reino Unido

k ViiV Healthcare, Brentford, Reino Unido

l GlaxoSmithKline, Brasil

Read

2055

Times
was read the article

890

Total PDF

1165

Total HTML

Share statistics

Article information

ISSN: 14138670
Original language: English

DOI:10.1016/j.bjid.2021.101720

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 April	37	24	61
2024 March	65	27	92
2024 February	75	31	106
2024 January	96	34	130
2023 December	73	25	98
2023 November	87	37	124
2023 October	64	33	97
2023 September	47	71	118
2023 August	32	31	63
2023 July	24	29	53
2023 June	32	21	53
2023 May	49	25	74
2023 April	26	21	47
2023 March	56	34	90
2023 February	40	31	71
2023 January	30	19	49
2022 December	53	35	88
2022 November	40	36	76
2022 October	40	23	63
2022 September	35	48	83
2022 August	30	28	58
2022 July	22	29	51
2022 June	28	42	70
2022 May	24	40	64
2022 April	18	32	50
2022 March	25	44	69
2022 February	17	40	57

Show all

Follow this link to access the full text of the article

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter